Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Q4 2018 Sarepta Therapeutics Inc Earnings Call Transcript

Feb 27, 2019 / 09:30PM GMT
Release Date Price: $148.77 (+2.76%)
Operator

Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2018 earnings call. (Operator Instructions) As a reminder, today's program is being recorded.

And now I'd like to introduce your host for today's program, Ian Estepan, Vice President, Chief of Staff and Corporate Affairs. Please go ahead.

Ian M. Estepan
Sarepta Therapeutics, Inc. - Chief of Staff & VP of Corporate Affairs

Thank you, Sophie, and thank you all for joining today's call. Earlier today, we released our financial results for fourth quarter and year end 2018. The press release is available on our website at www.sarepta.com.

Joining us on the call today are Doug Ingram; Sandy Mahatme; Bo Cumbo; Gilmore O'Neill; and Louise Rodino-Klapac. After our formal remarks, we'll open the call for Q&A.

I'd like to note that during this call, we will be making a number of forward-looking statements. Please take a moment to review our slide on the webcast, which

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot